Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey.
Tugay D, Top M, Aydin Ö, Bavbek S, Damadoğlu E, Öner Erkekol F, Koca Kalkan I, Kalyoncu AF, Karakaya G, Oğuzülgen IK, Türktaş H, Abraham I. Tugay D, et al. Among authors: abraham i. J Med Econ. 2023 Jan-Dec;26(1):720-730. doi: 10.1080/13696998.2023.2209417. J Med Econ. 2023. PMID: 37129881 Free article.
Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
McBride A, Campbell K, Bikkina M, MacDonald K, Abraham I, Balu S. McBride A, et al. Among authors: abraham i. J Med Econ. 2017 Oct;20(10):1083-1093. doi: 10.1080/13696998.2017.1358173. Epub 2017 Aug 4. J Med Econ. 2017. PMID: 28722494 Free article.
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma.
McBride A, Krendyukov A, Mathieson N, Campbell K, Balu S, Natek M, MacDonald K, Abraham I. McBride A, et al. Among authors: abraham i. J Med Econ. 2020 Jan;23(1):28-36. doi: 10.1080/13696998.2019.1658591. Epub 2019 Sep 3. J Med Econ. 2020. PMID: 31433700 Free article.
Pricing methods in outcome-based contracting: δ6: adherence-based pricing.
Alkhatib NS, Slack M, Bhattacharjee S, Erstad B, Ramos K, McBride A, Abraham I. Alkhatib NS, et al. Among authors: abraham i. J Med Econ. 2020 Nov;23(11):1256-1265. doi: 10.1080/13696998.2020.1815030. Epub 2020 Sep 10. J Med Econ. 2020. PMID: 32845209 Free article.
560 results